These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33187885)

  • 21. Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.
    Linder BJ; Frank I; Cheville JC; Thompson RH; Thapa P; Tarrell RF; Boorjian SA
    J Urol; 2013 May; 189(5):1670-5. PubMed ID: 23142686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?
    Kotb AF; Kovac E; Kassouf W; Chin J; Fradet Y; Izawa J; Estey E; Fairey A; Rendon R; Cagiannos I; Lacombe L; Lattouf JB; Bell D; Drachenberg D; Aprikian AG
    World J Urol; 2012 Dec; 30(6):761-7. PubMed ID: 22293934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma.
    Moschini M; Suardi N; Pellucchi F; Rocchini L; La Croce G; Capitanio U; Briganti A; Damiano R; Montorsi F; Colombo R
    Anticancer Res; 2014 Jun; 34(6):3225-30. PubMed ID: 24922698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy.
    May M; Brookman-May S; Burger M; Gilfrich C; Fritsche HM; Rink M; Chun F; Fisch M; Roghmann F; Noldus J; Mayr R; Pycha A; Novotny V; Wirth M; Vallo S; Haferkamp A; Roigas J; Brisuda A; Stredele R; Volkmer B; Dechet C; Schnabel M; Denzinger S; Stief CG; Bastian PJ; Aziz A
    Ann Surg Oncol; 2014 Nov; 21(12):4034-40. PubMed ID: 24895114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.
    Pagano F; Bassi P; Ferrante GL; Piazza N; Abatangelo G; Pappagallo GL; Garbeglio A
    J Urol; 1996 Jan; 155(1):244-7. PubMed ID: 7490845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-specific differences in survival among upper and lower tract urothelial carcinoma patients treated with radical surgery.
    Anno T; Kikuchi E; Shigeta K; Ogihara K; Watanabe K; Yanai Y; Takamatsu K; Hasegawa S; Masuda T; Oyama M; Mizuno R; Oya M
    Jpn J Clin Oncol; 2021 May; 51(6):984-991. PubMed ID: 33589927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection.
    Luo Q; Liu Y; Zhao H; Guo P; Wang Q; Li W; Li G; Wu B
    World J Urol; 2020 Nov; 38(11):2849-2856. PubMed ID: 31965287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.
    Knoedler JJ; Boorjian SA; Tollefson MK; Cheville JC; Thapa P; Tarrell RF; Frank I
    BJU Int; 2014 Dec; 114(6):832-6. PubMed ID: 24119219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.
    Tollefson MK; Boorjian SA; Farmer SA; Frank I
    World J Urol; 2012 Dec; 30(6):795-9. PubMed ID: 22447397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.
    Culp SH; Dickstein RJ; Grossman HB; Pretzsch SM; Porten S; Daneshmand S; Cai J; Groshen S; Siefker-Radtke A; Millikan RE; Czerniak B; Navai N; Wszolek MF; Kamat AM; Dinney CP
    J Urol; 2014 Jan; 191(1):40-7. PubMed ID: 23911605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
    Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study.
    Mao S; Wu Y; Wang R; Guo Y; Yuan J; Zhang W; Zhang J; Yan Y; Yao X
    Investig Clin Urol; 2020 Jul; 61(4):382-389. PubMed ID: 32665994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Xylinas E; Rink M; Robinson BD; Lotan Y; Babjuk M; Brisuda A; Green DA; Kluth LA; Pycha A; Fradet Y; Faison T; Lee RK; Karakiewicz PI; Zerbib M; Scherr DS; Shariat SF
    Eur J Cancer; 2013 May; 49(8):1889-97. PubMed ID: 23466126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study.
    Narita C; Urabe F; Fukuokaya W; Iwatani K; Imai Y; Yasue K; Mori K; Aikawa K; Yanagisawa T; Kimura S; Tashiro K; Tsuzuki S; Yamada Y; Yuen SKK; Teoh JY; Shimomura T; Yamada H; Furuta A; Miki J; Kimura T;
    Clin Genitourin Cancer; 2024 Jun; 22(3):102082. PubMed ID: 38641443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
    Moschini M; Zamboni S; Mattei A; Baumeister P; Di Bona C; Cornelius J; Shariat SF; Freschi M; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A;
    Urol Int; 2019; 102(3):269-276. PubMed ID: 30695782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.